Search for pathway correlated target
You are searching for: hsa04666
T68163 Target Info |
Target Name | Tyrosine-protein kinase Lyn (JTK8) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Bone disease; Solid tumour/cancer; | ||
Drugs | Bafetinib | Drug Info |
T14834 Target Info |
Target Name | Cytosolic phospholipase A2 (GIVA cPLA2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Atopic dermatitis; Asthma; | ||
Drugs | ZPL521 | Drug Info |
T23276 Target Info |
Target Name | Extracellular signal-regulated kinase 1 (ERK1) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Melanoma; Artery stenosis; | ||
Drugs | BVD-523 | Drug Info |
T23673 Target Info |
Target Name | Proto-oncogene c-RAF (c-RAF) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Autoimmune diabetes; Inflammatory bowel disease; | ||
Drugs | Semapimod | Drug Info |
T31989 Target Info |
Target Name | Sphingosine kinase 2 (SPHK2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Advanced solid tumour; Hepatocellular carcinoma; | ||
Drugs | ABC294640 | Drug Info |
T03573 Target Info |
Target Name | Immunoglobulin gamma Fc receptor IIB (FCGR2B) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Autoimmune diabetes; Systemic lupus erythematosus; | ||
Drugs | Xmab 5871 | Drug Info |
T59001 Target Info |
Target Name | Immunoglobulin gamma Fc receptor IIIA (FCGR3A) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Hodgkin lymphoma; Peripheral T-cell lymphoma; | ||
Drugs | AFM13 | Drug Info |
T10383 Target Info |
Target Name | Phospholipase D2 (PLD2) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Coagulation defect; | ||
Drugs | VU0364739 | Drug Info |
T83585 Target Info |
Target Name | Wiskott-Aldrich syndrome protein (WAS) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Wiskott-Aldrich syndrome; | ||
Drugs | OTL-103 | Drug Info |
T05351 Target Info |
Target Name | Myristoylated alanine-rich C-kinase substrate (MARCKS) | |
---|---|---|---|
Target type | Clinical trial Target | ||
Disease | Chronic obstructive pulmonary disease; Non-small-cell lung cancer; | ||
Drugs | BIO-11006 | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.